Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

STAAR Surgical Company (STAA): BroadWood Capital Buys 260K Shares Following Positive Earnings Report

Neal C. Bradsher’s BroadWood Capital disclosed yesterday the acquisition of 260,341 shares of STAAR Surgical Company (NASDAQ:STAA)’s Common Stock, for an average weighted price of approximately $9.19 per share. According to the Form 4 filed with the SEC, the fund now owns 7.14 million shares directly, while Neal C. Bradsher owns an extra 25,900 of them.

STAAR Surgical Company

BroadWood Capital is a private investment firm founded by Mr. Bradsher in 2002, and presided by him ever since. The fund last disclosed, for the second quarter of the year, a concentrated equity portfolio, comprising only 6 equity positions in the healthcare and consumer staples sectors, worth more than half a billion dollars in the market. Previous to starting his fund, Neal Bradsher worked at Whitehall Asset Management and Campbell Advisors.

STAAR Surgical Company (NASDAQ:STAA) is a $344.25 million market cap designer, developer, manufacturer and marketer of implantable lenses for the eye, including lenses used in corrective and cataracts surgery. According to the Form 4 filing (the fund owns more than 10% of the company’s stock), BroadWood purchased, through three separate transactions that took place on October 31, November 3 and November 4, a total of 260,341 shares of Common Stock, having spent about $2.39 million.

With its current position, which comprises more than 7.14 million shares, the fund asserts its dominance as the largest institutional shareholder in the company, trailed from far behind by William Leland Edwards’ Palo Alto Investors and Mark Broach’s Manatuck Hill Partners. These funds declared, by the end of the second quarter, owning 2.59 million shares and 271,600 shares, respectively.

But, what drove BroadWood’s purchase in this case? Well, the acquisitions started on the day after STAAR Surgical Company (NASDAQ:STAA) reported its third quarter financial results. Some highlights include total sales of $18.2 million, up from from $17.1 million in 2013’s third quarter GAAP-Net Loss of $0.07 per Share, and the approval of Visian ICL with CentraFLOW® for marketing in China.

Some other relevant moves made by BroadWood recently include an increase in its stake in BioTime, Inc. (NYSEMKT:BTX) to nearly 17.9 million shares, or 22% of the company’s outstanding stock. The fund has been bullish on BioTime for a while now, with purchases dating back to early-January.

Disclosure: Javier Hasse holds no positions in any stocks or funds mentioned

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!